Screening Asymptomatic Individuals for Factor V Leiden

Registration


There is no cost to participate. This on-demand course will take approximately 15 minutes to complete. After the assessment, learners will be asked to complete an activity with a passing score of 75%.

Before enrolling in this educational activity, you must log in or create an account. 

Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage.
 

Target Audience

Healthcare professionals.

Description

This webinar will address the professional practice gap in which inherited thrombophilias are screened for too frequently in patients with a positive family history of heterozygous Factor V Leiden, leading to a diagnosis when they have no other risk factors for venous thromboembolism. Ideally, the decision to screen a patient for FVL would consider other risk factors for VTE and the patient's overall lifetime risk. This course will provide education to current and future providers to take pause when deciding whether or not to screen a patient for this inherited thrombophilia based solely on a positive family history. 

Learning Objectives

  1. Discuss the prevalence and pathogenesis of the inherited thrombophilia Factor V Leiden, as well as identify the lifetime risk of venous thromboembolism for heterozygotes and homozygotes. 
  2. Summarize recent recommendations on the clinical utility of screening asymptomatic individuals, paying specific attention to universal screening, pregnant women, individuals considering combined oral contraceptive use and menopausal hormone therapy, and minors.
  3. Analyze recent data on the role of thrombophilia screening in primary thromboprophylaxis. 
  4. Explain why over-screening for Factor V Leiden can be harmful to patients and how targeted screening could be improved in clinical practice.

Speaker

Madison Taborek
Physician Assistant Student, Des Moines University Medicine and Health Sciences

Faculty Advisor

Karen Vandehaar, PA-C, ATC
Assistant Professor, Physician Assistant Studies Program, Des Moines University Medicine and Health Sciences

Ms. Vandehaar has reviewed the slides for completeness, clinical accuracy, and recommended action. 

Terms of Use and Privacy Policy

Recording date: February 9, 2026
Date of original release: February 9, 2026
Most recent review/update: February 9, 2026
Termination date: February 8, 2029

Course summary
Available credit: 
  • 0.25 AMA PRA Category 1 Credits™
  • 0.25 AOA Category 2­B
  • 0.25 CE Contact Hour(s)
Course opens: 
02/09/2026
Course expires: 
02/08/2029
Cost:
$0.00

Accreditation Statements

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University Medicine and Health Sciences (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 0.25 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Other Healthcare Professionals: This activity is designated for a maximum of 0.25 AMA PRA Category 1 Credit(s)™.

Educational Grants

No ineligible company provided financial support for this continuing education activity. 

Disclosures

The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

  • Madison Taborek - Speaker
  • Karen Vandehaar, PA-C, ATC - Faculty Advisor and Content Reviewer

Disclaimer

The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.

Available Credit

  • 0.25 AMA PRA Category 1 Credits™
  • 0.25 AOA Category 2­B
  • 0.25 CE Contact Hour(s)

Price

Cost:
$0.00
Please login or Create an Account to take this course.